- Home
- Daily Diary
- Asset Class
- Sector
- Latest
- Author
- Street Notes
- TheStreet
- Switch to
+0.00| Last Update: 05/17/13 - 4:00 PM EDT |
| Volume: 5,391,732 |
| YTD Performance: -16.58% |
| Open: $18.71 |
| Previous Close: $18.62 |
| 52 Week Range: $18.00 - $25.89 |
| Oustanding Shares: 317,750,908 |
| Market Cap: 5,916,521,907 |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Qtr (06/13) | Qtr (09/13) | FY (09/13) | FY (09/14) | |
|---|---|---|---|---|
| Average Estimate | $0.20 | $0.23 | $0.90 | $1.00 |
| Number of Analysts | 7 | 7 | 7 | 7 |
| High Estimate | $0.24 | $0.32 | $1.03 | $1.23 |
| Low Estimate | $0.15 | $0.11 | $0.76 | $0.78 |
| Prior Year | $0.33 | $0.33 | $1.69 | $0.90 |
| Growth Rate (Year over Year) | -39.83% | -31.17% | -46.91% | 11.46% |
Here's how some current events and attitudes line up with Buffett's philosophy.
Amid all the bluster and flow of earnings, some perspective is needed.
Nuance downgraded at Morgan StanleyNUAN was downgraded to Equal-weight, Morgan Stanley said. Company is facing increased growth risks.
I’ve found a number of confirming data points for these stocks.
These two inexpensive stocks will likely also benefit from this renowned investor advocate's activism.
These stocks all pique my interest at current levels.
A bullishly-biased, longer-term options strategy in this voice and language solution innovator.
Nuance downgraded at NeedhamNUAN was downgraded from Buy to Hold, Needham said. Company is seeing lower international sales and demand from healthcare customers.
The vast majority of the company is a medical transcription business.